Author:
Fallah Nader,Mohammad Kazem,Nourijelyani Keramat,Eshraghian Mohammad Reza,Seyyedsalehi Seyyed Ali,Raiessi Maria,Rahmani Maziar,Goodarzi Hamid Reza,Darvish Soodabeh,Zeraati Hojjat,Davoodi Gholamreza,Sadeghian Saeed
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev. 2003;24:313–40. doi: 10.1210/er.2003-0005 .
2. Callies F, Stromer H, Schwinger RH, et al. Administration of testosterone is associated with a reduced susceptibility to myocardial ischemia. Endocrinology. 2003;144:4478–83. doi: 10.1210/en.2003-0058 .
3. Channer KS, Jones TH. Cardiovascular effects of testosterone: implications of the “male menopause”? Heart. 2003;89:121–2. doi: 10.1136/heart.89.2.121 .
4. Dobs AS, Bachorik PS, Arver S, et al. Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system. J Clin Endocrinol Metab. 2001;86:1026–33. doi: 10.1210/jc.86.3.1026 .
5. Malkin CJ, Pugh PJ, Jones TH, Channer KS. Testosterone for secondary prevention in men with ischaemic heart disease? QJM. 2003;96:521–9. doi: 10.1093/qjmed/hcg086 .
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献